Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. GM
7. SMCI
8. NOW
9. EFX
10. IBM

Go back to Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program
(NASDAQ: KYMR) Delayed: 110.34 -3.03 (2.67%)
Previous Close $113.37    52 Week High $ 
Open $110.92    52 Week Low $ 
Day High $113.63    P/E N/A 
Day Low $110.18    EPS $ 
Volume 538,338